| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.03e-09 | 46 | 21 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.26e-06 | 188 | 21 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 8.32e-06 | 126 | 21 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | dATP binding | 1.05e-05 | 5 | 21 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.58e-05 | 6 | 21 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 2.19e-05 | 161 | 21 | 4 | GO:0051087 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 2.21e-05 | 7 | 21 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 3.78e-05 | 9 | 21 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.80e-05 | 441 | 21 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.24e-04 | 1160 | 21 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.27e-04 | 1356 | 21 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.60e-04 | 134 | 21 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.65e-04 | 614 | 21 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 6.37e-04 | 163 | 21 | 3 | GO:0031072 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 8.02e-04 | 40 | 21 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.05e-03 | 775 | 21 | 5 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.50e-03 | 839 | 21 | 5 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.51e-03 | 840 | 21 | 5 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.51e-03 | 840 | 21 | 5 | GO:0016818 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.81e-03 | 875 | 21 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.96e-03 | 891 | 21 | 5 | GO:0005198 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 1.98e-03 | 63 | 21 | 2 | GO:0030544 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.54e-03 | 562 | 21 | 4 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.65e-03 | 73 | 21 | 2 | GO:0044183 | |
| GeneOntologyMolecularFunction | p53 binding | 2.94e-03 | 77 | 21 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.76e-03 | 303 | 21 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | nucleosome binding | 4.71e-03 | 98 | 21 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 7.79e-03 | 127 | 21 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 1.18e-02 | 158 | 21 | 2 | GO:0004386 | |
| GeneOntologyBiologicalProcess | regulation of protein refolding | 1.82e-08 | 6 | 21 | 3 | GO:0061083 | |
| GeneOntologyBiologicalProcess | protein refolding | 2.14e-08 | 30 | 21 | 4 | GO:0042026 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 1.26e-07 | 46 | 21 | 4 | GO:0006458 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 3.29e-07 | 14 | 21 | 3 | GO:1903332 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.54e-06 | 377 | 21 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.57e-06 | 378 | 21 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.59e-06 | 379 | 21 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 5.83e-06 | 35 | 21 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 9.46e-06 | 41 | 21 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | regulation of protein import | 9.85e-06 | 5 | 21 | 2 | GO:1904589 | |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 9.85e-06 | 5 | 21 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 2.07e-05 | 7 | 21 | 2 | GO:1903333 | |
| GeneOntologyBiologicalProcess | anterior head development | 2.75e-05 | 8 | 21 | 2 | GO:0097065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 6.10e-05 | 76 | 21 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 7.11e-05 | 80 | 21 | 3 | GO:0061077 | |
| GeneOntologyBiologicalProcess | protein folding | 1.01e-04 | 246 | 21 | 4 | GO:0006457 | |
| GeneOntologyBiologicalProcess | protein import | 1.17e-04 | 16 | 21 | 2 | GO:0017038 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.19e-04 | 95 | 21 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.88e-04 | 111 | 21 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | notochord development | 2.69e-04 | 24 | 21 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | protein maturation | 3.27e-04 | 619 | 21 | 5 | GO:0051604 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 3.35e-04 | 135 | 21 | 3 | GO:0051702 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 3.94e-04 | 29 | 21 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 3.96e-04 | 143 | 21 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 4.21e-04 | 146 | 21 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 5.80e-04 | 163 | 21 | 3 | GO:0002456 | |
| GeneOntologyBiologicalProcess | protein transmembrane import into intracellular organelle | 7.52e-04 | 40 | 21 | 2 | GO:0044743 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 8.29e-04 | 42 | 21 | 2 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 9.10e-04 | 44 | 21 | 2 | GO:0045023 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.04e-03 | 47 | 21 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.37e-03 | 54 | 21 | 2 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.61e-03 | 232 | 21 | 3 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.65e-03 | 234 | 21 | 3 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.67e-03 | 235 | 21 | 3 | GO:0002822 | |
| GeneOntologyBiologicalProcess | head development | 1.95e-03 | 919 | 21 | 5 | GO:0060322 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.98e-03 | 65 | 21 | 2 | GO:0045815 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 2.04e-03 | 252 | 21 | 3 | GO:0002819 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 2.16e-03 | 68 | 21 | 2 | GO:0141137 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 2.33e-03 | 957 | 21 | 5 | GO:0097435 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 2.50e-03 | 271 | 21 | 3 | GO:0000082 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 2.51e-03 | 579 | 21 | 4 | GO:0045785 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 2.55e-03 | 74 | 21 | 2 | GO:0002711 | |
| GeneOntologyBiologicalProcess | protein transmembrane transport | 2.69e-03 | 76 | 21 | 2 | GO:0071806 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 2.90e-03 | 1483 | 21 | 6 | GO:0048646 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 2.90e-03 | 79 | 21 | 2 | GO:0060350 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 3.03e-03 | 290 | 21 | 3 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of type I interferon production | 3.05e-03 | 81 | 21 | 2 | GO:0032481 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.23e-11 | 21 | 21 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen trimer | 2.41e-10 | 88 | 21 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.91e-07 | 12 | 21 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.91e-07 | 12 | 21 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 9.59e-06 | 5 | 21 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.01e-05 | 530 | 21 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.10e-05 | 1187 | 21 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.62e-05 | 332 | 21 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.68e-05 | 8 | 21 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.68e-05 | 8 | 21 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.68e-05 | 8 | 21 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.38e-05 | 656 | 21 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.44e-05 | 658 | 21 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | bBAF complex | 4.30e-05 | 10 | 21 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 8.68e-05 | 14 | 21 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 1.14e-04 | 16 | 21 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | basement membrane | 2.39e-04 | 122 | 21 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.11e-04 | 30 | 21 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | supramolecular fiber | 8.28e-04 | 1179 | 21 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.14e-03 | 96 | 21 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 7.35e-03 | 129 | 21 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear matrix | 8.60e-03 | 140 | 21 | 2 | GO:0016363 | |
| HumanPheno | Short phalanx of the 5th toe | 1.27e-05 | 3 | 11 | 2 | HP:0100368 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 2.54e-05 | 4 | 11 | 2 | HP:0010343 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 4.22e-05 | 5 | 11 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 4.22e-05 | 5 | 11 | 2 | HP:0010342 | |
| HumanPheno | Prominent interphalangeal joints | 6.33e-05 | 6 | 11 | 2 | HP:0006237 | |
| HumanPheno | Recurrent upper respiratory tract infections | 7.67e-05 | 237 | 11 | 5 | HP:0002788 | |
| HumanPheno | Short distal phalanx of the 5th finger | 8.85e-05 | 7 | 11 | 2 | HP:0004227 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 5th finger | 8.85e-05 | 7 | 11 | 2 | HP:0009239 | |
| HumanPheno | Abnormal nasopharynx morphology | 9.72e-05 | 249 | 11 | 5 | HP:0001739 | |
| HumanPheno | Abnormal pharynx morphology | 1.20e-04 | 260 | 11 | 5 | HP:0033151 | |
| HumanPheno | Dislocated radial head | 1.75e-04 | 54 | 11 | 3 | HP:0003083 | |
| HumanPheno | Abnormality of the radial head | 2.06e-04 | 57 | 11 | 3 | HP:0003995 | |
| HumanPheno | Abnormality of the humeroradial joint | 2.64e-04 | 62 | 11 | 3 | HP:0100744 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 2.77e-04 | 12 | 11 | 2 | HP:0010746 | |
| HumanPheno | Short 5th finger | 2.91e-04 | 64 | 11 | 3 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 3.18e-04 | 66 | 11 | 3 | HP:0006262 | |
| HumanPheno | Abnormality of the pharynx | 3.20e-04 | 320 | 11 | 5 | HP:0000600 | |
| HumanPheno | Hypoplastic fifth fingernail | 3.80e-04 | 14 | 11 | 2 | HP:0008398 | |
| HumanPheno | Recurrent sinusitis | 4.47e-04 | 74 | 11 | 3 | HP:0011108 | |
| HumanPheno | Prominent eyelashes | 5.67e-04 | 17 | 11 | 2 | HP:0011231 | |
| HumanPheno | Oral aversion | 5.67e-04 | 17 | 11 | 2 | HP:0012523 | |
| MousePheno | retrognathia | 3.66e-05 | 7 | 19 | 2 | MP:0004282 | |
| MousePheno | decreased cornea stroma thickness | 7.83e-05 | 10 | 19 | 2 | MP:0003092 | |
| Domain | Collagen | 3.82e-10 | 85 | 21 | 6 | PF01391 | |
| Domain | Collagen | 3.82e-10 | 85 | 21 | 6 | IPR008160 | |
| Domain | Fib_collagen_C | 2.01e-07 | 11 | 21 | 3 | IPR000885 | |
| Domain | NC1_FIB | 2.01e-07 | 11 | 21 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 2.01e-07 | 11 | 21 | 3 | PD002078 | |
| Domain | COLFI | 2.01e-07 | 11 | 21 | 3 | SM00038 | |
| Domain | COLFI | 2.01e-07 | 11 | 21 | 3 | PF01410 | |
| Domain | SSDP_DNA-bd | 3.61e-06 | 3 | 21 | 2 | IPR008116 | |
| Domain | STI1_HS-bd | 5.39e-05 | 10 | 21 | 2 | IPR006636 | |
| Domain | STI1 | 5.39e-05 | 10 | 21 | 2 | SM00727 | |
| Domain | RRM_1 | 7.71e-05 | 208 | 21 | 4 | PF00076 | |
| Domain | RRM | 9.08e-05 | 217 | 21 | 4 | SM00360 | |
| Domain | RRM_dom | 1.08e-04 | 227 | 21 | 4 | IPR000504 | |
| Domain | RRM | 1.14e-04 | 230 | 21 | 4 | PS50102 | |
| Domain | - | 1.43e-04 | 244 | 21 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.77e-04 | 258 | 21 | 4 | IPR012677 | |
| Domain | LisH | 4.47e-04 | 28 | 21 | 2 | IPR006594 | |
| Domain | LISH | 4.47e-04 | 28 | 21 | 2 | PS50896 | |
| Domain | LisH | 4.47e-04 | 28 | 21 | 2 | SM00667 | |
| Domain | VWC | 4.47e-04 | 28 | 21 | 2 | PF00093 | |
| Domain | C1Q | 5.85e-04 | 32 | 21 | 2 | SM00110 | |
| Domain | C1q | 5.85e-04 | 32 | 21 | 2 | PF00386 | |
| Domain | C1q_dom | 6.61e-04 | 34 | 21 | 2 | IPR001073 | |
| Domain | C1Q | 6.61e-04 | 34 | 21 | 2 | PS50871 | |
| Domain | VWFC_1 | 7.41e-04 | 36 | 21 | 2 | PS01208 | |
| Domain | VWC | 8.26e-04 | 38 | 21 | 2 | SM00214 | |
| Domain | VWFC_2 | 8.26e-04 | 38 | 21 | 2 | PS50184 | |
| Domain | VWF_dom | 1.01e-03 | 42 | 21 | 2 | IPR001007 | |
| Domain | - | 1.43e-03 | 50 | 21 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 1.92e-03 | 58 | 21 | 2 | IPR008983 | |
| Domain | TPR_1 | 4.54e-03 | 90 | 21 | 2 | PF00515 | |
| Domain | TPR_1 | 4.54e-03 | 90 | 21 | 2 | IPR001440 | |
| Domain | TPR | 9.12e-03 | 129 | 21 | 2 | SM00028 | |
| Domain | TPR-contain_dom | 1.22e-02 | 150 | 21 | 2 | IPR013026 | |
| Domain | TPR | 1.46e-02 | 165 | 21 | 2 | PS50005 | |
| Domain | TPR_REGION | 1.46e-02 | 165 | 21 | 2 | PS50293 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.95e-09 | 44 | 18 | 5 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.05e-08 | 61 | 18 | 5 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.70e-08 | 67 | 18 | 5 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.61e-08 | 90 | 18 | 5 | M631 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.83e-07 | 41 | 18 | 4 | MM15538 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.94e-07 | 46 | 18 | 4 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.13e-07 | 50 | 18 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.24e-07 | 53 | 18 | 4 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.28e-07 | 61 | 18 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.13e-06 | 64 | 18 | 4 | M26953 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.97e-06 | 20 | 18 | 3 | MM15061 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.02e-06 | 74 | 18 | 4 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.25e-06 | 76 | 18 | 4 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.25e-06 | 76 | 18 | 4 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.53e-06 | 85 | 18 | 4 | M16441 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.95e-06 | 30 | 18 | 3 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.47e-06 | 32 | 18 | 3 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.14e-05 | 114 | 18 | 4 | MM14571 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.43e-05 | 38 | 18 | 3 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.81e-05 | 41 | 18 | 3 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.95e-05 | 42 | 18 | 3 | M7169 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.56e-05 | 140 | 18 | 4 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.88e-05 | 300 | 18 | 5 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.90e-05 | 57 | 18 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.16e-05 | 58 | 18 | 3 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.43e-05 | 59 | 18 | 3 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.62e-05 | 63 | 18 | 3 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.61e-05 | 66 | 18 | 3 | M18 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.03e-04 | 73 | 18 | 3 | MM14948 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.16e-04 | 76 | 18 | 3 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.30e-04 | 79 | 18 | 3 | M27643 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.04e-04 | 92 | 18 | 3 | MM14951 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.60e-04 | 19 | 18 | 2 | MM15512 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.74e-04 | 258 | 18 | 4 | MM14572 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.28e-04 | 532 | 18 | 5 | M27870 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.11e-04 | 575 | 18 | 5 | M29853 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 6.13e-04 | 29 | 18 | 2 | M48076 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.56e-04 | 30 | 18 | 2 | MM15517 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 7.01e-04 | 31 | 18 | 2 | M39522 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 8.94e-04 | 35 | 18 | 2 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 9.99e-04 | 37 | 18 | 2 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.29e-03 | 42 | 18 | 2 | M48237 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.61e-03 | 47 | 18 | 2 | MM14925 | |
| Pathway | WP_MRNA_PROCESSING | 2.21e-03 | 451 | 18 | 4 | MM15946 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | 3.05e-03 | 65 | 18 | 2 | M590 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.24e-03 | 67 | 18 | 2 | MM15345 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.17e-03 | 261 | 18 | 3 | MM15676 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 4.37e-03 | 78 | 18 | 2 | M27234 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 4.81e-03 | 82 | 18 | 2 | MM17230 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 4.81e-03 | 82 | 18 | 2 | M27250 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.05e-03 | 84 | 18 | 2 | M7098 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.41e-03 | 95 | 18 | 2 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 6.67e-03 | 97 | 18 | 2 | M48262 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 6.81e-03 | 98 | 18 | 2 | M48249 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.89e-03 | 1432 | 18 | 6 | M509 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.22e-03 | 101 | 18 | 2 | M27253 | |
| Pathway | WP_THERMOGENESIS | 8.21e-03 | 108 | 18 | 2 | M39746 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 8.51e-03 | 110 | 18 | 2 | M48043 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 8.96e-03 | 113 | 18 | 2 | M48336 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 4.37e-09 | 704 | 21 | 8 | 32994395 | |
| Pubmed | 9.51e-09 | 122 | 21 | 5 | 29530978 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 9.97e-09 | 269 | 21 | 6 | 30442662 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 1.31e-08 | 130 | 21 | 5 | 32905556 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 5.35e-08 | 62 | 21 | 4 | 28344315 | |
| Pubmed | 5.81e-08 | 175 | 21 | 5 | 28071719 | ||
| Pubmed | 6.19e-08 | 1431 | 21 | 9 | 37142655 | ||
| Pubmed | SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | 6.91e-08 | 66 | 21 | 4 | 36095012 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.21e-07 | 1082 | 21 | 8 | 38697112 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.60e-07 | 430 | 21 | 6 | 38172120 | |
| Pubmed | 1.83e-07 | 19 | 21 | 3 | 31186351 | ||
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.98e-07 | 224 | 21 | 5 | 28443643 | |
| Pubmed | 2.43e-07 | 90 | 21 | 4 | 30459231 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 3.09e-07 | 807 | 21 | 7 | 30575818 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.28e-07 | 486 | 21 | 6 | 30940648 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 3.33e-07 | 23 | 21 | 3 | 30962207 | |
| Pubmed | 3.42e-07 | 250 | 21 | 5 | 33536335 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 12890148 | ||
| Pubmed | A molecular chaperone complex at the lysosomal membrane is required for protein translocation. | 3.47e-07 | 2 | 21 | 2 | 11559757 | |
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 3.47e-07 | 2 | 21 | 2 | 35562743 | |
| Pubmed | 4.15e-07 | 260 | 21 | 5 | 36199071 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 5.24e-07 | 109 | 21 | 4 | 33554859 | |
| Pubmed | 5.37e-07 | 274 | 21 | 5 | 34244482 | ||
| Pubmed | 5.50e-07 | 27 | 21 | 3 | 17725712 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 6.30e-07 | 283 | 21 | 5 | 28533407 | |
| Pubmed | 6.63e-07 | 286 | 21 | 5 | 32041737 | ||
| Pubmed | 7.62e-07 | 30 | 21 | 3 | 25864199 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.50e-07 | 954 | 21 | 7 | 36373674 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 9.83e-07 | 1425 | 21 | 8 | 30948266 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 23815551 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 1.04e-06 | 3 | 21 | 2 | 22426308 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 32910019 | ||
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 1.04e-06 | 3 | 21 | 2 | 1297453 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 12642495 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 17331945 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 12079286 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.17e-06 | 605 | 21 | 6 | 28977666 | |
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | 1.21e-06 | 323 | 21 | 5 | 25959826 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.23e-06 | 135 | 21 | 4 | 28675934 | |
| Pubmed | 1.27e-06 | 136 | 21 | 4 | 21280222 | ||
| Pubmed | 1.29e-06 | 615 | 21 | 6 | 31048545 | ||
| Pubmed | 1.51e-06 | 142 | 21 | 4 | 30809309 | ||
| Pubmed | 1.60e-06 | 638 | 21 | 6 | 33239621 | ||
| Pubmed | 1.69e-06 | 346 | 21 | 5 | 25324306 | ||
| Pubmed | 1.71e-06 | 39 | 21 | 3 | 33580754 | ||
| Pubmed | 1.86e-06 | 655 | 21 | 6 | 35819319 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.03e-06 | 153 | 21 | 4 | 26365490 | |
| Pubmed | 2.03e-06 | 153 | 21 | 4 | 28225217 | ||
| Pubmed | The carboxyl-terminal lobe of Hsc70 ATPase domain is sufficient for binding to BAG1. | 2.08e-06 | 4 | 21 | 2 | 11741305 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 20806039 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 28863077 | ||
| Pubmed | Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development. | 2.08e-06 | 4 | 21 | 2 | 12381786 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 11093761 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 2.08e-06 | 4 | 21 | 2 | 15170388 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 2.08e-06 | 4 | 21 | 2 | 11988099 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 11687574 | ||
| Pubmed | 2.37e-06 | 159 | 21 | 4 | 22751105 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 2.65e-06 | 45 | 21 | 3 | 25496916 | |
| Pubmed | 2.83e-06 | 46 | 21 | 3 | 20890123 | ||
| Pubmed | 2.89e-06 | 707 | 21 | 6 | 19738201 | ||
| Pubmed | 3.08e-06 | 1139 | 21 | 7 | 36417873 | ||
| Pubmed | 3.31e-06 | 173 | 21 | 4 | 23979707 | ||
| Pubmed | 3.34e-06 | 1153 | 21 | 7 | 29845934 | ||
| Pubmed | 3.39e-06 | 399 | 21 | 5 | 37536630 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 15870273 | ||
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 3.47e-06 | 5 | 21 | 2 | 9659900 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 12200431 | ||
| Pubmed | 3.50e-06 | 731 | 21 | 6 | 29298432 | ||
| Pubmed | 3.65e-06 | 50 | 21 | 3 | 23658023 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.92e-06 | 411 | 21 | 5 | 35182466 | |
| Pubmed | 4.30e-06 | 419 | 21 | 5 | 15635413 | ||
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 4.70e-06 | 189 | 21 | 4 | 29449217 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 21467034 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 5.20e-06 | 6 | 21 | 2 | 25081545 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 18790094 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 5.20e-06 | 6 | 21 | 2 | 8563024 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 17876790 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 7813775 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.45e-06 | 440 | 21 | 5 | 34244565 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 5.90e-06 | 1257 | 21 | 7 | 37317656 | |
| Pubmed | 6.00e-06 | 803 | 21 | 6 | 36517590 | ||
| Pubmed | 6.98e-06 | 463 | 21 | 5 | 34901782 | ||
| Pubmed | 7.01e-06 | 62 | 21 | 3 | 19463158 | ||
| Pubmed | Gene-environment interaction in the etiology of mathematical ability using SNP sets. | 7.28e-06 | 7 | 21 | 2 | 20978832 | |
| Pubmed | Messenger RNA expression of heat shock proteins (HSPs) during ocular development. | 7.28e-06 | 7 | 21 | 2 | 8974842 | |
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 7.28e-06 | 7 | 21 | 2 | 21118156 | |
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 23540691 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 15647277 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 21445275 | ||
| Pubmed | 7.97e-06 | 844 | 21 | 6 | 25963833 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 8.13e-06 | 847 | 21 | 6 | 35235311 | |
| Pubmed | 8.47e-06 | 66 | 21 | 3 | 23275444 | ||
| Pubmed | 8.66e-06 | 484 | 21 | 5 | 31995728 | ||
| Pubmed | 8.87e-06 | 67 | 21 | 3 | 25253489 | ||
| Pubmed | 9.28e-06 | 491 | 21 | 5 | 22623428 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 9.55e-06 | 1353 | 21 | 7 | 29467282 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 9.70e-06 | 8 | 21 | 2 | 20059976 | |
| Pubmed | Evidence for hSNM1B/Apollo functioning in the HSP70 mediated DNA damage response. | 9.70e-06 | 8 | 21 | 2 | 19411856 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 10382266 | ||
| Interaction | TRIM33 interactions | 9.65e-09 | 453 | 21 | 8 | int:TRIM33 | |
| Interaction | PDLIM4 interactions | 1.51e-08 | 27 | 21 | 4 | int:PDLIM4 | |
| Interaction | PACSIN3 interactions | 2.01e-07 | 131 | 21 | 5 | int:PACSIN3 | |
| Interaction | STOML2 interactions | 2.35e-07 | 267 | 21 | 6 | int:STOML2 | |
| Interaction | NANOG interactions | 3.68e-07 | 481 | 21 | 7 | int:NANOG | |
| Interaction | SOX2 interactions | SSBP3 HSPD1 G3BP1 SMARCA4 COL8A1 HSPA8 EWSR1 MYEF2 ARID1B HNRNPM | 5.09e-07 | 1422 | 21 | 10 | int:SOX2 |
| Interaction | COL2A1 interactions | 5.31e-07 | 64 | 21 | 4 | int:COL2A1 | |
| Interaction | COLGALT2 interactions | 6.40e-07 | 67 | 21 | 4 | int:COLGALT2 | |
| Interaction | UBQLN2 interactions | 7.43e-07 | 797 | 21 | 8 | int:UBQLN2 | |
| Interaction | ST13P4 interactions | 9.35e-07 | 19 | 21 | 3 | int:ST13P4 | |
| Interaction | METTL14 interactions | 9.97e-07 | 558 | 21 | 7 | int:METTL14 | |
| Interaction | PACSIN2 interactions | 1.12e-06 | 185 | 21 | 5 | int:PACSIN2 | |
| Interaction | FN1 interactions | 1.19e-06 | 848 | 21 | 8 | int:FN1 | |
| Interaction | GATA2 interactions | 1.60e-06 | 199 | 21 | 5 | int:GATA2 | |
| Interaction | ZEB1 interactions | 1.64e-06 | 200 | 21 | 5 | int:ZEB1 | |
| Interaction | SLFN11 interactions | 1.74e-06 | 376 | 21 | 6 | int:SLFN11 | |
| Interaction | BCL9 interactions | 1.75e-06 | 86 | 21 | 4 | int:BCL9 | |
| Interaction | BRD7 interactions | 2.41e-06 | 637 | 21 | 7 | int:BRD7 | |
| Interaction | OGT interactions | 2.78e-06 | 950 | 21 | 8 | int:OGT | |
| Interaction | ERG interactions | 2.79e-06 | 223 | 21 | 5 | int:ERG | |
| Interaction | DNAJC8 interactions | 3.25e-06 | 230 | 21 | 5 | int:DNAJC8 | |
| Interaction | AR interactions | 3.84e-06 | 992 | 21 | 8 | int:AR | |
| Interaction | PRPF40A interactions | 4.65e-06 | 446 | 21 | 6 | int:PRPF40A | |
| Interaction | MEN1 interactions | 5.04e-06 | 1029 | 21 | 8 | int:MEN1 | |
| Interaction | RBMX interactions | 5.62e-06 | 461 | 21 | 6 | int:RBMX | |
| Interaction | GLUD1 interactions | 5.69e-06 | 258 | 21 | 5 | int:GLUD1 | |
| Interaction | LCK interactions | 5.76e-06 | 463 | 21 | 6 | int:LCK | |
| Interaction | TBXT interactions | 5.78e-06 | 116 | 21 | 4 | int:TBXT | |
| Interaction | RPS6KB2 interactions | 6.02e-06 | 261 | 21 | 5 | int:RPS6KB2 | |
| Interaction | SCARNA22 interactions | 6.19e-06 | 118 | 21 | 4 | int:SCARNA22 | |
| Interaction | PRMT5 interactions | 6.36e-06 | 471 | 21 | 6 | int:PRMT5 | |
| Interaction | SSBP3 interactions | 6.40e-06 | 119 | 21 | 4 | int:SSBP3 | |
| Interaction | ERCC8 interactions | 7.54e-06 | 124 | 21 | 4 | int:ERCC8 | |
| Interaction | SMARCE1 interactions | 9.55e-06 | 287 | 21 | 5 | int:SMARCE1 | |
| Interaction | GNS interactions | 1.09e-05 | 136 | 21 | 4 | int:GNS | |
| Interaction | COL8A2 interactions | 1.09e-05 | 42 | 21 | 3 | int:COL8A2 | |
| Interaction | CLIC4 interactions | 1.15e-05 | 138 | 21 | 4 | int:CLIC4 | |
| Interaction | LINC01554 interactions | 1.29e-05 | 142 | 21 | 4 | int:LINC01554 | |
| Interaction | ZSWIM4 interactions | 1.55e-05 | 6 | 21 | 2 | int:ZSWIM4 | |
| Interaction | TBX5 interactions | 1.60e-05 | 150 | 21 | 4 | int:TBX5 | |
| Interaction | BCL9L interactions | 1.64e-05 | 48 | 21 | 3 | int:BCL9L | |
| Interaction | GLDC interactions | 1.64e-05 | 321 | 21 | 5 | int:GLDC | |
| Interaction | CUL4A interactions | 1.65e-05 | 854 | 21 | 7 | int:CUL4A | |
| Interaction | KCND3 interactions | 1.74e-05 | 49 | 21 | 3 | int:KCND3 | |
| Interaction | FAF1 interactions | 1.99e-05 | 334 | 21 | 5 | int:FAF1 | |
| Interaction | POU5F1 interactions | 2.16e-05 | 584 | 21 | 6 | int:POU5F1 | |
| Interaction | MCCC2 interactions | 2.16e-05 | 162 | 21 | 4 | int:MCCC2 | |
| Interaction | RRBP1 interactions | 2.19e-05 | 341 | 21 | 5 | int:RRBP1 | |
| Interaction | CAND1 interactions | 2.22e-05 | 894 | 21 | 7 | int:CAND1 | |
| Interaction | CUL2 interactions | 2.31e-05 | 591 | 21 | 6 | int:CUL2 | |
| Interaction | SIRT2 interactions | 2.33e-05 | 165 | 21 | 4 | int:SIRT2 | |
| Interaction | LHX4 interactions | 2.38e-05 | 166 | 21 | 4 | int:LHX4 | |
| Interaction | SNRPD1 interactions | 2.38e-05 | 347 | 21 | 5 | int:SNRPD1 | |
| Interaction | FBP1 interactions | 2.42e-05 | 348 | 21 | 5 | int:FBP1 | |
| Interaction | EWSR1 interactions | 2.42e-05 | 906 | 21 | 7 | int:EWSR1 | |
| Interaction | CIITA interactions | 2.47e-05 | 55 | 21 | 3 | int:CIITA | |
| Interaction | HEXIM1 interactions | 2.55e-05 | 913 | 21 | 7 | int:HEXIM1 | |
| Interaction | MECP2 interactions | 2.60e-05 | 1287 | 21 | 8 | int:MECP2 | |
| Interaction | GMPS interactions | 2.74e-05 | 172 | 21 | 4 | int:GMPS | |
| Interaction | EPAS1 interactions | 2.80e-05 | 173 | 21 | 4 | int:EPAS1 | |
| Interaction | RANBP2 interactions | 2.88e-05 | 361 | 21 | 5 | int:RANBP2 | |
| Interaction | AGR2 interactions | 2.95e-05 | 934 | 21 | 7 | int:AGR2 | |
| Interaction | MOB3C interactions | 3.00e-05 | 364 | 21 | 5 | int:MOB3C | |
| Interaction | PUF60 interactions | 3.20e-05 | 369 | 21 | 5 | int:PUF60 | |
| Interaction | SIRT6 interactions | 3.25e-05 | 628 | 21 | 6 | int:SIRT6 | |
| Interaction | HNRNPAB interactions | 3.28e-05 | 371 | 21 | 5 | int:HNRNPAB | |
| Interaction | BIRC3 interactions | 3.37e-05 | 1334 | 21 | 8 | int:BIRC3 | |
| Interaction | LHX2 interactions | 3.49e-05 | 183 | 21 | 4 | int:LHX2 | |
| Interaction | FLI1 interactions | 3.54e-05 | 62 | 21 | 3 | int:FLI1 | |
| Interaction | SMARCA1 interactions | 3.88e-05 | 188 | 21 | 4 | int:SMARCA1 | |
| Interaction | KDM4A interactions | 3.90e-05 | 64 | 21 | 3 | int:KDM4A | |
| Interaction | FOXRED1 interactions | 3.90e-05 | 64 | 21 | 3 | int:FOXRED1 | |
| Interaction | COL5A1 interactions | 4.09e-05 | 65 | 21 | 3 | int:COL5A1 | |
| Interaction | MATR3 interactions | 4.12e-05 | 655 | 21 | 6 | int:MATR3 | |
| Interaction | PRRC2A interactions | 4.12e-05 | 389 | 21 | 5 | int:PRRC2A | |
| Interaction | MYCN interactions | 4.15e-05 | 1373 | 21 | 8 | int:MYCN | |
| Interaction | PABPN1 interactions | 4.21e-05 | 192 | 21 | 4 | int:PABPN1 | |
| Interaction | BICRA interactions | 4.48e-05 | 67 | 21 | 3 | int:BICRA | |
| Interaction | SMC5 interactions | 4.57e-05 | 1000 | 21 | 7 | int:SMC5 | |
| Interaction | USP48 interactions | 4.60e-05 | 668 | 21 | 6 | int:USP48 | |
| Interaction | KCTD13 interactions | 4.63e-05 | 1394 | 21 | 8 | int:KCTD13 | |
| Interaction | CIMAP1C interactions | 4.63e-05 | 10 | 21 | 2 | int:CIMAP1C | |
| Interaction | CTNNBL1 interactions | 4.65e-05 | 197 | 21 | 4 | int:CTNNBL1 | |
| Interaction | STIP1 interactions | 4.74e-05 | 1006 | 21 | 7 | int:STIP1 | |
| Interaction | ARMC5 interactions | 5.03e-05 | 201 | 21 | 4 | int:ARMC5 | |
| Interaction | PYCR1 interactions | 5.23e-05 | 203 | 21 | 4 | int:PYCR1 | |
| Interaction | GATA4 interactions | 5.35e-05 | 411 | 21 | 5 | int:GATA4 | |
| Interaction | TEDC2 interactions | 5.54e-05 | 206 | 21 | 4 | int:TEDC2 | |
| Interaction | RNF113A interactions | 5.60e-05 | 692 | 21 | 6 | int:RNF113A | |
| Interaction | RBM45 interactions | 5.64e-05 | 207 | 21 | 4 | int:RBM45 | |
| Interaction | SFXN1 interactions | 5.73e-05 | 417 | 21 | 5 | int:SFXN1 | |
| Interaction | SNIP1 interactions | 5.73e-05 | 417 | 21 | 5 | int:SNIP1 | |
| Interaction | ZFP36L2 interactions | 6.08e-05 | 211 | 21 | 4 | int:ZFP36L2 | |
| Interaction | KDM4C interactions | 6.53e-05 | 76 | 21 | 3 | int:KDM4C | |
| Interaction | TRMT10C interactions | 6.54e-05 | 215 | 21 | 4 | int:TRMT10C | |
| Interaction | MRPL39 interactions | 6.66e-05 | 216 | 21 | 4 | int:MRPL39 | |
| Interaction | ST13P5 interactions | 6.78e-05 | 12 | 21 | 2 | int:ST13P5 | |
| Interaction | PTPN2 interactions | 7.53e-05 | 223 | 21 | 4 | int:PTPN2 | |
| Interaction | NSUN4 interactions | 7.90e-05 | 81 | 21 | 3 | int:NSUN4 | |
| Interaction | LRRC28 interactions | 8.01e-05 | 13 | 21 | 2 | int:LRRC28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 1.33e-03 | 118 | 21 | 2 | chr5q33 | |
| GeneFamily | Collagens | 3.64e-10 | 46 | 16 | 5 | 490 | |
| GeneFamily | RNA binding motif containing | 3.05e-05 | 213 | 16 | 4 | 725 | |
| Coexpression | NABA_COLLAGENS | 1.86e-10 | 43 | 21 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.10e-10 | 44 | 21 | 5 | M3005 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 7.09e-08 | 761 | 21 | 8 | M11961 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 4.03e-07 | 380 | 21 | 6 | M41703 | |
| Coexpression | ZHANG_UTERUS_C7_EPITHELIAL2_CELL | 1.91e-06 | 799 | 21 | 7 | MM16613 | |
| Coexpression | NABA_CORE_MATRISOME | 1.99e-06 | 270 | 21 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.17e-06 | 275 | 21 | 5 | M5884 | |
| Coexpression | RHODES_CANCER_META_SIGNATURE | 1.88e-05 | 65 | 21 | 3 | M1345 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 2.01e-05 | 1144 | 21 | 7 | MM3843 | |
| Coexpression | SEMBA_FHIT_TARGETS_UP | 3.35e-05 | 11 | 21 | 2 | M14812 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 7.56e-05 | 1407 | 21 | 7 | M14427 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 9.09e-05 | 304 | 21 | 4 | M39208 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 9.20e-05 | 305 | 21 | 4 | M19875 | |
| Coexpression | NABA_MATRISOME | 1.05e-04 | 1008 | 21 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.16e-04 | 1026 | 21 | 6 | M5889 | |
| Coexpression | LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB | 1.61e-04 | 353 | 21 | 4 | M39229 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.45e-04 | 29 | 21 | 2 | MM17055 | |
| Coexpression | GILDEA_METASTASIS | 2.45e-04 | 29 | 21 | 2 | M2386 | |
| Coexpression | RUIZ_TNC_TARGETS_UP | 2.54e-04 | 156 | 21 | 3 | M988 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 2.62e-04 | 30 | 21 | 2 | M1550 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 2.80e-04 | 31 | 21 | 2 | MM665 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 2.99e-04 | 32 | 21 | 2 | MM668 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 2.99e-04 | 32 | 21 | 2 | M1558 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 3.16e-04 | 421 | 21 | 4 | MM985 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 3.27e-04 | 170 | 21 | 3 | M6822 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.58e-04 | 35 | 21 | 2 | MM17054 | |
| Coexpression | CHANDRAN_METASTASIS_TOP50_UP | 4.00e-04 | 37 | 21 | 2 | M18970 | |
| Coexpression | MALONEY_RESPONSE_TO_17AAG_UP | 4.68e-04 | 40 | 21 | 2 | M1857 | |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN | 4.81e-04 | 194 | 21 | 3 | M7580 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN | 4.83e-04 | 471 | 21 | 4 | M19016 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP | 5.11e-04 | 198 | 21 | 3 | M8649 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 5.11e-04 | 198 | 21 | 3 | M6112 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP | 5.18e-04 | 199 | 21 | 3 | M6741 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 5.18e-04 | 199 | 21 | 3 | M5284 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_DN | 5.26e-04 | 200 | 21 | 3 | M5595 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP | 5.26e-04 | 200 | 21 | 3 | M4599 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN | 5.26e-04 | 200 | 21 | 3 | M4589 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP | 5.26e-04 | 200 | 21 | 3 | M4830 | |
| Coexpression | GSE17721_LPS_VS_CPG_24H_BMDC_DN | 5.26e-04 | 200 | 21 | 3 | M4011 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 5.26e-04 | 200 | 21 | 3 | M5901 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN | 5.26e-04 | 200 | 21 | 3 | M4386 | |
| Coexpression | HUMMEL_BURKITTS_LYMPHOMA_UP | 5.41e-04 | 43 | 21 | 2 | M3134 | |
| Coexpression | CHANDRAN_METASTASIS_TOP50_DN | 5.67e-04 | 44 | 21 | 2 | M17043 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 6.08e-04 | 1394 | 21 | 6 | M9585 | |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 7.03e-04 | 49 | 21 | 2 | M39116 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 7.61e-04 | 946 | 21 | 5 | M39169 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | 7.76e-04 | 950 | 21 | 5 | M19907 | |
| Coexpression | LOPEZ_MBD_TARGETS | 7.87e-04 | 953 | 21 | 5 | M4120 | |
| Coexpression | FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL | 7.99e-04 | 231 | 21 | 3 | M41719 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 8.09e-04 | 232 | 21 | 3 | MM1019 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 8.24e-04 | 543 | 21 | 4 | MM997 | |
| Coexpression | FISCHER_DREAM_TARGETS | 8.48e-04 | 969 | 21 | 5 | M149 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 8.53e-04 | 54 | 21 | 2 | M1349 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | 8.82e-04 | 553 | 21 | 4 | M1475 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 9.17e-04 | 56 | 21 | 2 | MM564 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 9.25e-04 | 243 | 21 | 3 | M14072 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 9.26e-04 | 988 | 21 | 5 | M6616 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | 1.19e-03 | 1045 | 21 | 5 | M8525 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | 1.22e-03 | 604 | 21 | 4 | M45760 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 185 | 20 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 188 | 20 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-06 | 189 | 20 | 4 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-06 | 189 | 20 | 4 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-06 | 191 | 20 | 4 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-06 | 194 | 20 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 196 | 20 | 4 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 196 | 20 | 4 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 198 | 20 | 4 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-06 | 198 | 20 | 4 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 198 | 20 | 4 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 198 | 20 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 198 | 20 | 4 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 199 | 20 | 4 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-06 | 199 | 20 | 4 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-06 | 199 | 20 | 4 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-06 | 199 | 20 | 4 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.70e-06 | 199 | 20 | 4 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 199 | 20 | 4 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-06 | 200 | 20 | 4 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-06 | 200 | 20 | 4 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-06 | 200 | 20 | 4 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 200 | 20 | 4 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|Megakaryo-cells / Lineage, cell class and subclass | 1.74e-06 | 200 | 20 | 4 | f36023bb369d17b8ec8724616737738e3df01987 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-06 | 200 | 20 | 4 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-06 | 200 | 20 | 4 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-06 | 200 | 20 | 4 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue | 2.53e-05 | 129 | 20 | 3 | 426dfed68ce7ccc38d02e671e722e201f9eb1ce0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.64e-05 | 158 | 20 | 3 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.72e-05 | 159 | 20 | 3 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.72e-05 | 159 | 20 | 3 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 166 | 20 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 166 | 20 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 167 | 20 | 3 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 167 | 20 | 3 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.66e-05 | 169 | 20 | 3 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-05 | 169 | 20 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-05 | 173 | 20 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 173 | 20 | 3 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-05 | 173 | 20 | 3 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-05 | 173 | 20 | 3 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.28e-05 | 175 | 20 | 3 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.39e-05 | 176 | 20 | 3 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-05 | 176 | 20 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.39e-05 | 176 | 20 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-05 | 176 | 20 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.61e-05 | 178 | 20 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 178 | 20 | 3 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.61e-05 | 178 | 20 | 3 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-05 | 178 | 20 | 3 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.72e-05 | 179 | 20 | 3 | 02218c048e4dec0c0a3d63d2abb4feb4c3e82697 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 181 | 20 | 3 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.06e-05 | 182 | 20 | 3 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.06e-05 | 182 | 20 | 3 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.29e-05 | 184 | 20 | 3 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.29e-05 | 184 | 20 | 3 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.77e-05 | 188 | 20 | 3 | 9858940c616e43441644c5a3bea8d832ee4daf79 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.77e-05 | 188 | 20 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.89e-05 | 189 | 20 | 3 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 189 | 20 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 189 | 20 | 3 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 189 | 20 | 3 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 190 | 20 | 3 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.02e-05 | 190 | 20 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 190 | 20 | 3 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 190 | 20 | 3 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 191 | 20 | 3 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-05 | 191 | 20 | 3 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.14e-05 | 191 | 20 | 3 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 191 | 20 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 191 | 20 | 3 | 8a67dc87c926c826a09cf6469c8ebf90c80b06db | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 192 | 20 | 3 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 192 | 20 | 3 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 8.27e-05 | 192 | 20 | 3 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 8.40e-05 | 193 | 20 | 3 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 80380358f44c2f4781676ec0f1fa94d4c69080d6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 1559d25b3f1c4ea268478ac26ba13f166b96f1dc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 2946e8c9328e356cda3dafe7c86e8de462df37da | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 194 | 20 | 3 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 8.53e-05 | 194 | 20 | 3 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 194 | 20 | 3 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.53e-05 | 194 | 20 | 3 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-05 | 194 | 20 | 3 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.66e-05 | 195 | 20 | 3 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.66e-05 | 195 | 20 | 3 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.66e-05 | 195 | 20 | 3 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 2416efe0b10ef28d0107808d1347bc34f87f92b7 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.66e-05 | 195 | 20 | 3 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| Computational | Neighborhood of SMC1L1 | 1.40e-04 | 62 | 18 | 3 | MORF_SMC1L1 | |
| Computational | Neighborhood of PCNA | 3.33e-04 | 83 | 18 | 3 | MORF_PCNA | |
| Computational | Genes in the cancer module 155. | 7.77e-04 | 25 | 18 | 2 | MODULE_155 | |
| Computational | Genes in the cancer module 245. | 8.41e-04 | 26 | 18 | 2 | MODULE_245 | |
| Computational | Protein folding. | 1.05e-03 | 29 | 18 | 2 | MODULE_355 | |
| Drug | AC1LAKND | 1.91e-09 | 62 | 20 | 5 | CID000470146 | |
| Drug | BAPN | 4.05e-07 | 71 | 20 | 4 | CID000001647 | |
| Drug | halofuginone lactate | 8.37e-07 | 85 | 20 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.10e-06 | 91 | 20 | 4 | CID000000825 | |
| Drug | ticlopidine | 1.81e-06 | 103 | 20 | 4 | CID000005472 | |
| Drug | hydroxylysine | 2.27e-06 | 109 | 20 | 4 | CID000001029 | |
| Drug | AC1L1KMJ | 2.45e-06 | 476 | 20 | 6 | CID000030956 | |
| Drug | Tranilast sodium | 2.81e-06 | 115 | 20 | 4 | CID000005527 | |
| Drug | isodesmosine | 3.11e-06 | 33 | 20 | 3 | CID000013811 | |
| Drug | GK-101 | 4.06e-06 | 36 | 20 | 3 | CID000161853 | |
| Drug | pirfenidone | 5.81e-06 | 138 | 20 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 5.97e-06 | 139 | 20 | 4 | CID000004727 | |
| Drug | PCR 4099 | 5.97e-06 | 139 | 20 | 4 | CID000002806 | |
| Drug | Albendazole | 8.59e-06 | 46 | 20 | 3 | ctd:D015766 | |
| Drug | Madecassol | 8.59e-06 | 46 | 20 | 3 | CID000108062 | |
| Drug | d-indobufen | 1.11e-05 | 50 | 20 | 3 | CID000044562 | |
| Drug | ridogrel | 1.25e-05 | 52 | 20 | 3 | CID005362391 | |
| Drug | NSC49633 | 1.32e-05 | 53 | 20 | 3 | CID000023340 | |
| Drug | desmosine | 1.32e-05 | 53 | 20 | 3 | CID000025435 | |
| Drug | khellin | 1.35e-05 | 171 | 20 | 4 | CID000003828 | |
| Drug | isohumulone | 1.54e-05 | 7 | 20 | 2 | CID000093090 | |
| Drug | 4-hops | 1.54e-05 | 7 | 20 | 2 | CID000135862 | |
| Drug | AC1L1DD6 | 1.62e-05 | 179 | 20 | 4 | CID000002299 | |
| Drug | malotilate | 3.19e-05 | 71 | 20 | 3 | CID000004006 | |
| Drug | AC1NMZ1B | 3.76e-05 | 75 | 20 | 3 | CID005034185 | |
| Drug | strontium ranelate | 4.07e-05 | 77 | 20 | 3 | CID006918182 | |
| Drug | AC1Q6PCP | 4.33e-05 | 230 | 20 | 4 | CID000005267 | |
| Drug | Ant-dATP | 4.81e-05 | 12 | 20 | 2 | CID000131323 | |
| Drug | hyaluronan | 7.29e-05 | 263 | 20 | 4 | CID000024759 | |
| Drug | Ivermectin | 7.62e-05 | 95 | 20 | 3 | ctd:D007559 | |
| Drug | mosapramine | 7.64e-05 | 15 | 20 | 2 | CID000004257 | |
| Drug | rutin | 8.36e-05 | 98 | 20 | 3 | CID005280805 | |
| Drug | avridine | 8.73e-05 | 16 | 20 | 2 | CID000037186 | |
| Drug | SD-282 | 8.73e-05 | 16 | 20 | 2 | CID014973220 | |
| Drug | fluoride | 9.03e-05 | 278 | 20 | 4 | CID000014917 | |
| Drug | silibinin | 9.94e-05 | 285 | 20 | 4 | CID000005213 | |
| Drug | b-Mo | 1.11e-04 | 18 | 20 | 2 | CID011427297 | |
| Drug | AC1L1C2F | 1.18e-04 | 110 | 20 | 3 | CID000001711 | |
| Drug | AC1L3C9O | 1.18e-04 | 110 | 20 | 3 | CID000002521 | |
| Drug | AC1L1BNR | 1.24e-04 | 19 | 20 | 2 | CID000001526 | |
| Drug | PPACK | 1.28e-04 | 113 | 20 | 3 | CID003036757 | |
| Drug | AC1L9732 | 1.31e-04 | 114 | 20 | 3 | CID000439300 | |
| Drug | B-F-H | 1.38e-04 | 20 | 20 | 2 | CID000027690 | |
| Drug | 351A | 1.38e-04 | 20 | 20 | 2 | CID000122144 | |
| Drug | Ro 15-4513 | 1.38e-04 | 20 | 20 | 2 | CID000005081 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.44e-04 | 314 | 20 | 4 | CID000447989 | |
| Drug | Cyclophosphamide | 1.47e-04 | 607 | 20 | 5 | ctd:D003520 | |
| Drug | AC1L18QD | 1.65e-04 | 325 | 20 | 4 | CID000000213 | |
| Drug | Selara | 1.72e-04 | 125 | 20 | 3 | CID000150310 | |
| Drug | DMSe | 2.02e-04 | 132 | 20 | 3 | CID000020796 | |
| Drug | 2d41 | 2.54e-04 | 27 | 20 | 2 | CID009543496 | |
| Drug | candesartan cilexetil | 2.66e-04 | 145 | 20 | 3 | CID000002540 | |
| Drug | JS-1 | 2.73e-04 | 28 | 20 | 2 | CID000129920 | |
| Drug | poly(propyleneimine) | 2.73e-04 | 28 | 20 | 2 | ctd:C443641 | |
| Drug | AC1O581Q | 2.93e-04 | 29 | 20 | 2 | CID006453768 | |
| Drug | losartan | 2.93e-04 | 378 | 20 | 4 | CID000003961 | |
| Drug | colchine | 3.09e-04 | 383 | 20 | 4 | CID000002833 | |
| Drug | AC1L1AUZ | 3.36e-04 | 157 | 20 | 3 | CID000001160 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 3.69e-04 | 162 | 20 | 3 | CID000072363 | |
| Drug | diphenylamine-2-carboxylate | 3.82e-04 | 164 | 20 | 3 | CID000004386 | |
| Drug | Warfarin | 3.96e-04 | 166 | 20 | 3 | ctd:D014859 | |
| Drug | phenylpropionic acid | 4.03e-04 | 167 | 20 | 3 | CID000000107 | |
| Drug | chondroitin sulfate | 4.11e-04 | 413 | 20 | 4 | CID000024766 | |
| Drug | Sirius red | 4.29e-04 | 35 | 20 | 2 | CID005486818 | |
| Drug | indeno(1,2,3-cd)pyrene | 4.47e-04 | 173 | 20 | 3 | ctd:C041508 | |
| Drug | AC1L1K9Q | 5.06e-04 | 38 | 20 | 2 | CID000005399 | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 5.18e-04 | 182 | 20 | 3 | 1231_DN | |
| Drug | AC1MRIIV | 5.33e-04 | 39 | 20 | 2 | CID003518584 | |
| Drug | L-azetidine-2-carboxylic acid | 5.60e-04 | 40 | 20 | 2 | CID000016486 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.78e-04 | 189 | 20 | 3 | CID000001413 | |
| Drug | foscarnet | 5.87e-04 | 190 | 20 | 3 | CID000003414 | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 4647_DN | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 2561_UP | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 1233_DN | |
| Drug | Thiostrepton | 6.18e-04 | 42 | 20 | 2 | ctd:D013883 | |
| Drug | Hyaluronic Acid | 6.24e-04 | 194 | 20 | 3 | ctd:D006820 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4581_DN | |
| Drug | PD123177 | 6.48e-04 | 43 | 20 | 2 | CID000114899 | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4160_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 5099_UP | |
| Drug | NC-4 | 6.78e-04 | 44 | 20 | 2 | CID006420119 | |
| Drug | Curcumin | 6.96e-04 | 850 | 20 | 5 | ctd:D003474 | |
| Drug | CD437 | 7.12e-04 | 203 | 20 | 3 | CID000135411 | |
| Drug | Raloxifene Hydrochloride | 7.22e-04 | 857 | 20 | 5 | ctd:D020849 | |
| Drug | fulvestrant | 7.46e-04 | 484 | 20 | 4 | ctd:C070081 | |
| Drug | AC1L1KZZ | 7.74e-04 | 47 | 20 | 2 | CID000005725 | |
| Drug | Lovastatin | 7.96e-04 | 211 | 20 | 3 | ctd:D008148 | |
| Drug | Chloroprene | 8.04e-04 | 1348 | 20 | 6 | ctd:D002737 | |
| Drug | hexadec-11-enal | 8.07e-04 | 48 | 20 | 2 | CID000062073 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.82e-06 | 5 | 21 | 2 | C3281201 | |
| Disease | Coffin-Siris syndrome | 3.75e-05 | 13 | 21 | 2 | C0265338 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 2.07e-04 | 30 | 21 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | Acute Coronary Syndrome | 2.51e-04 | 33 | 21 | 2 | C0948089 | |
| Disease | cortical surface area measurement | 2.67e-04 | 1345 | 21 | 6 | EFO_0010736 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 5.39e-04 | 227 | 21 | 3 | EFO_0004346, EFO_0010736 | |
| Disease | breast carcinoma | 6.24e-04 | 1019 | 21 | 5 | EFO_0000305 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.50e-04 | 53 | 21 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPGGPGGPMGRMGGR | 476 | Q01844 | |
| GGPGGMRGGRGGLMD | 566 | Q01844 | |
| QQGGGMMMGPGGGGA | 456 | Q8NFD5 | |
| PGMGAMGGMGGGMGG | 556 | P10809 | |
| LGVMQGPMGPMGPRG | 196 | P02458 | |
| GNFPGGMPGMGGDMP | 291 | Q8NFI4 | |
| GMPGMGGDMPGMAGM | 296 | Q8NFI4 | |
| GGDMPGMAGMPGLNE | 301 | Q8NFI4 | |
| GNFPGGMPGMGGGMP | 291 | P50502 | |
| GMPGMGGGMPGMAGM | 296 | P50502 | |
| GGGMPGMAGMPGLNE | 301 | P50502 | |
| MATTGGMGMGPGGPG | 161 | P52272 | |
| GMGMGPGGPGMITIP | 166 | P52272 | |
| MGNIGPAGMGMEGIG | 326 | P52272 | |
| PGPSGMMGRMGFPGK | 51 | Q9BXJ5 | |
| GGLGGGMRGPPRGGM | 436 | Q13283 | |
| FPGTKGEMGMMGPPG | 891 | P29400 | |
| TGPMGAMGPLGPRGM | 326 | P05997 | |
| GMPGMPGKPGAMGMP | 161 | P27658 | |
| KGSMGHPGMPGGMGT | 1026 | Q8IZC6 | |
| GMSMGGAPAGPAGTG | 1971 | Q8TE73 | |
| GMPGGMPGGFPGGGA | 616 | P11142 | |
| NMMMGGGGSFSAGGP | 341 | Q10713 | |
| NALGGPGMPGMNMGP | 201 | P81877 | |
| MGPGSDGPMGGLGGM | 286 | P81877 | |
| PMGPGSDGPMGGMGG | 311 | Q9BWW4 | |
| MGNLGPGGMGMDGPG | 356 | Q9P2K5 | |
| PGGMGMDGPGFGGMN | 361 | Q9P2K5 | |
| MGMRSGGHAGMGPPP | 96 | P51532 | |
| MSGGPMGGRPGGRGA | 1 | P42768 |